Skip to main content
Erschienen in: European Journal of Pediatrics 3/2022

15.10.2021 | Original Article

Effects of oral iodine supplementation in very low birth weight preterm infants for the prevention of thyroid function alterations during the neonatal period: results of a randomised assessor-blinded pilot trial and neurodevelopmental outcomes at 24 months

verfasst von: S. Ares, B. Saenz-Rico, J. Arnaez, J. Diez-Sebastian, F. Omeñaca, J. Bernal

Erschienen in: European Journal of Pediatrics | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

The trace element iodine (I) is essential for the synthesis of thyroid hormones. Parenteral nutrition solutions, formula milk, and human breast milk contain insufficient iodine to meet recommended intake for preterm infants. Iodine deficiency may affect thyroid function and may be associated with morbidity or neurological outcomes. The primary objective is to assess the evidence that dietary supplementation with iodine affects thyroid function during the neonatal period. The design was a randomised controlled pilot trial. Infants who met the inclusion criteria were enrolled through consecutive sampling and assigned to two different groups. The setting was a Spanish university hospital. Ninety-four patients with very low birth weight (under 1500 g) were included. Intervention group: 30 µg I/kg/day of iodine in oral drops given to 47 infants from their first day of life until hospital discharge. Control group: 47 infants without supplements. Formula and maternal milk samples for the determination of iodine content were collected at 1, 7, 15, 21, 30 days, and at discharge. Blood samples were collected for thyroid hormones. Neurological development was assessed at 2 years of age (Bayley III Test). Infants in the supplemented group reached the recommended levels from the first days of life. The researchers detected the effects of iodine balance on the plasma levels of thyroid hormones measured during the first 12 weeks of age. The trial assessed the impact of the intervention on neurodevelopmental morbidity.
Conclusion: Thyroid function is related to iodine intake in preterm infants. Therefore, supplements should be added if iodine intake is found to be inadequate. The analyses found no effects of iodine supplementation on the composite scores for Bayley-III assessments in all major domains. The study results indicate potentially important effects on language development related to low iodine excretion during the first 4 weeks of life
What is Known:
• Thyroid function is related to iodine intake in preterm infants.
• Preterm babies on formula preparations and with exclusive parenteral nutrition are at high risk of iodine deficiency.
What is New:
• Iodine intake should be monitored during the neonatal period.
• Iodine supplements should be added if iodine intake is found to be inadequate.
Literatur
2.
Zurück zum Zitat Bernal J, Nunez J (1995) Thyroid hormones and brain development. Eur J Endocrinol 133:390–398CrossRef Bernal J, Nunez J (1995) Thyroid hormones and brain development. Eur J Endocrinol 133:390–398CrossRef
3.
Zurück zum Zitat Morreale De Escobar G, Obregon MJ, Del Rey FE (2014) Maternal thyroid hormones early in pregnancy and foetal brain development. Best Pract Res Clin Endocrinol Metab 18: 225–248 Morreale De Escobar G, Obregon MJ, Del Rey FE (2014) Maternal thyroid hormones early in pregnancy and foetal brain development. Best Pract Res Clin Endocrinol Metab 18: 225–248
4.
Zurück zum Zitat De Vries LS, Heckmatt JZ, Burrin JM, Dubowitz LM, Dubowitz V (1986) Low serum thyroxine concentrations and neural maturation in preterm infants. Arch Dis Child 61:862–866CrossRef De Vries LS, Heckmatt JZ, Burrin JM, Dubowitz LM, Dubowitz V (1986) Low serum thyroxine concentrations and neural maturation in preterm infants. Arch Dis Child 61:862–866CrossRef
5.
Zurück zum Zitat Van Wassenaer AG, Kok JH, Dekker FW, De Vijlder JJM (1997) Thyroid function in very preterm infants: influences of gestational age and disease. Pediatr Res 42:604–609CrossRef Van Wassenaer AG, Kok JH, Dekker FW, De Vijlder JJM (1997) Thyroid function in very preterm infants: influences of gestational age and disease. Pediatr Res 42:604–609CrossRef
6.
Zurück zum Zitat Fisher DA, Klein AH (1981) Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 304:702–712CrossRef Fisher DA, Klein AH (1981) Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 304:702–712CrossRef
7.
Zurück zum Zitat Morreale De Escobar G, Ares S (1998) The hypothyroxinemia of prematurity. J Clin Endocrinol Metab 83: 713–715 Morreale De Escobar G, Ares S (1998) The hypothyroxinemia of prematurity. J Clin Endocrinol Metab 83: 713–715
8.
Zurück zum Zitat La Gamma EF, Van Wassenaer AG, Ares S, Golombek SG, Kok JH, Quero J et al (2009) Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks’ gestation. Pediatrics 124:258–268CrossRef La Gamma EF, Van Wassenaer AG, Ares S, Golombek SG, Kok JH, Quero J et al (2009) Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks’ gestation. Pediatrics 124:258–268CrossRef
9.
Zurück zum Zitat Van Wassenaer-Leemhuis A, Ares S, Golombek S, Kok J, Paneth N, Kase J et al (2014) Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months. Thyroid 24:1162–1169CrossRef Van Wassenaer-Leemhuis A, Ares S, Golombek S, Kok J, Paneth N, Kase J et al (2014) Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months. Thyroid 24:1162–1169CrossRef
13.
Zurück zum Zitat Williams FL, Watson J, Ogston S, Hume R, Willatts P, Visser T (2012) The Scottish Preterm Thyroid Group mild maternal thyroid dysfunction at delivery of infants born ≤34 weeks and neurodevelopmental outcome at 5.5 years. J Clin Endocrinol Metab 97:1977–1985. https://doi.org/10.1210/jc.2011-2451. Williams FL, Watson J, Ogston S, Hume R, Willatts P, Visser T (2012) The Scottish Preterm Thyroid Group mild maternal thyroid dysfunction at delivery of infants born ≤34 weeks and neurodevelopmental outcome at 5.5 years. J Clin Endocrinol Metab 97:1977–1985. https://​doi.​org/​10.​1210/​jc.​2011-2451.
14.
Zurück zum Zitat Ares S, Quero J, Morreale De Escobar G (2007) Spanish Preterm Thyroid Group. Iodine during the neonatal period: too little, too much? J Pediatr Endocrinol Metab 20: 163–166 Ares S, Quero J, Morreale De Escobar G (2007) Spanish Preterm Thyroid Group. Iodine during the neonatal period: too little, too much? J Pediatr Endocrinol Metab 20: 163–166
15.
Zurück zum Zitat Ares S, Quero J, Morreale De Escobar G (2005) Neonatal iodine deficiency: clinical aspects. J Pediatr Endocrinol Metab 18: 1257–1264 Ares S, Quero J, Morreale De Escobar G (2005) Neonatal iodine deficiency: clinical aspects. J Pediatr Endocrinol Metab 18: 1257–1264
16.
Zurück zum Zitat Ares S, Quero J, Duran S, Presas MJ, Herruzo R, Morreale De Escobar G (1994) Iodine content of infant formulas and iodine intake of premature babies: high risk of iodine deficiency. Arch Dis Child 71: 184–191 Ares S, Quero J, Duran S, Presas MJ, Herruzo R, Morreale De Escobar G (1994) Iodine content of infant formulas and iodine intake of premature babies: high risk of iodine deficiency. Arch Dis Child 71: 184–191
17.
Zurück zum Zitat Ares S, Garcia P, Quero J, Morreale De Escobar G (2004) Iodine intake and urinary excretion in premature infants born after less than 30 weeks of gestation. J Clin Ped Endocrinol 17: 509 Ares S, Garcia P, Quero J, Morreale De Escobar G (2004) Iodine intake and urinary excretion in premature infants born after less than 30 weeks of gestation. J Clin Ped Endocrinol 17: 509
18.
Zurück zum Zitat Ares S, Quero J, Morreale De Escobar G (2005) Neonatal iodine deficiency: clinical aspects. J Pediatr Endocrinol Metabol 18: 1257–1264 Ares S, Quero J, Morreale De Escobar G (2005) Neonatal iodine deficiency: clinical aspects. J Pediatr Endocrinol Metabol 18: 1257–1264
20.
Zurück zum Zitat Ares S, Garcia P, Quero J, Morreale De Escobar G (2004) Parameters of thyroid function in premature infants born at 25–30 weeks of gestation and their relation to pathology and medication during the neonatal period. J Clin Ped Endocrinol 17: 511 Ares S, Garcia P, Quero J, Morreale De Escobar G (2004) Parameters of thyroid function in premature infants born at 25–30 weeks of gestation and their relation to pathology and medication during the neonatal period. J Clin Ped Endocrinol 17: 511
23.
Zurück zum Zitat World Health Organization (2001) United Nations Children’s Fund, International Council for the Control of Iodine Deficiency Disorders. Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination: A Guide for Programme Managers (WHO/NHD/01.1). Geneva, Switzerland: World Health Organization World Health Organization (2001) United Nations Children’s Fund, International Council for the Control of Iodine Deficiency Disorders. Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination: A Guide for Programme Managers (WHO/NHD/01.1). Geneva, Switzerland: World Health Organization
27.
Zurück zum Zitat Ibrahim M, Morreale De Escobar G, Visser TJ, Duran S, Van Toor H, Strachan J et al (2003) Iodine deficiency associated with parenteral nutrition in extreme preterm infants. Arch Dis Child 88: 56–57 Ibrahim M, Morreale De Escobar G, Visser TJ, Duran S, Van Toor H, Strachan J et al (2003) Iodine deficiency associated with parenteral nutrition in extreme preterm infants. Arch Dis Child 88: 56–57
35.
Zurück zum Zitat Williams F, Hume R (2011) The measurement, definition, aetiology and clinical consequences of neonatal transient hypothyroxinaemia. Ann Clin Biochem 8(Pt 1):7–22. [PUBMED:20930033] Williams F, Hume R (2011) The measurement, definition, aetiology and clinical consequences of neonatal transient hypothyroxinaemia. Ann Clin Biochem 8(Pt 1):7–22. [PUBMED:20930033]
36.
Zurück zum Zitat Belykh N, Mamenko M, Kovalenko N, Minyaylo N, Plugatarenko N (2014) Effectiveness of iodine prophylaxis in pregnant, lactating, mothers and infants in mild iodine deficiency region. European Thyroid Journal 3(Suppl 1):117–118 Belykh N, Mamenko M, Kovalenko N, Minyaylo N, Plugatarenko N (2014) Effectiveness of iodine prophylaxis in pregnant, lactating, mothers and infants in mild iodine deficiency region. European Thyroid Journal 3(Suppl 1):117–118
37.
Zurück zum Zitat Bouhouch RR, Bouhouch S, Stinca S, Cherkaoui M, Aboussad A, Andersson M et al (2013) Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB J 27 Suppl 1:lb1–1217.39 Bouhouch RR, Bouhouch S, Stinca S, Cherkaoui M, Aboussad A, Andersson M et al (2013) Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB J 27 Suppl 1:lb1–1217.39
38.
Zurück zum Zitat Reuss ML, Leviton A, Paneth N, Susser M (1997) Thyroxine values from newborn screening of 919 infants born before 29 weeks’ gestation. Am J Public Health 87(10):1693–7. [PUBMED: 9357357] Reuss ML, Leviton A, Paneth N, Susser M (1997) Thyroxine values from newborn screening of 919 infants born before 29 weeks’ gestation. Am J Public Health 87(10):1693–7. [PUBMED: 9357357]
39.
Zurück zum Zitat Lucas A, Morley R, Fewtrell MS (1996) Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ 312(7039):1132–3. [PUBMED: 8620130] Lucas A, Morley R, Fewtrell MS (1996) Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ 312(7039):1132–3. [PUBMED: 8620130]
40.
Zurück zum Zitat Meijer WJ, Verloove-Vanhorick SP, Brand R, van den Brande JL (1992) Transient hypothyroxinaemia associated with developmental delay in very preterm infants. Arch Dis Childhood 67(7):944–7. [PUBMED: 1381573] Meijer WJ, Verloove-Vanhorick SP, Brand R, van den Brande JL (1992) Transient hypothyroxinaemia associated with developmental delay in very preterm infants. Arch Dis Childhood 67(7):944–7. [PUBMED: 1381573]
41.
42.
Zurück zum Zitat Biswas S, Buffery J, Enoch H, Martin Bland J, Walters D, Markiewicz M (2002) A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks’ gestation during the first 2 weeks of life and their relationship to outcome. Paediatrics 109:222–227CrossRef Biswas S, Buffery J, Enoch H, Martin Bland J, Walters D, Markiewicz M (2002) A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks’ gestation during the first 2 weeks of life and their relationship to outcome. Paediatrics 109:222–227CrossRef
46.
Zurück zum Zitat Ares S, Saenz-Rico B, Diez JMD, Bernal J (2016) Iodine intake, thyroid function and neurodevelopmental outcome in preterm infants from 24 to 30 weeks gestation. J Paediatri Endocrinol 1(3):1011 Ares S, Saenz-Rico B, Diez JMD, Bernal J (2016) Iodine intake, thyroid function and neurodevelopmental outcome in preterm infants from 24 to 30 weeks gestation. J Paediatri Endocrinol 1(3):1011
47.
Zurück zum Zitat Ares S, Quero J, Diez J, Morreale De Escobar G (2011) Neurodevelopment of preterm infants born at 28 to 36 weeks of gestational age: the role of hypothyroxinemia and long-term outcome at 4 years. J Paediatr Endocr Met 24: 897–902 Ares S, Quero J, Diez J, Morreale De Escobar G (2011) Neurodevelopment of preterm infants born at 28 to 36 weeks of gestational age: the role of hypothyroxinemia and long-term outcome at 4 years. J Paediatr Endocr Met 24: 897–902
48.
Zurück zum Zitat Benotti J, Benotti N (1963) Protein-bound iodine, total iodine and butanol-extractable iodine by partial automation. ClinChem 9:408–416 Benotti J, Benotti N (1963) Protein-bound iodine, total iodine and butanol-extractable iodine by partial automation. ClinChem 9:408–416
49.
Zurück zum Zitat Francis-Williams J, Yule W (1967) The Bayley Infant Scales of Mental and Motor Development. An exploratory study with an English sample. Dev Med Child Neurol. 9: 391–401 Francis-Williams J, Yule W (1967) The Bayley Infant Scales of Mental and Motor Development. An exploratory study with an English sample. Dev Med Child Neurol. 9: 391–401
52.
Zurück zum Zitat Van Wassenaer AG, Kok JH, De Vijlder JJ, Briet JM, Smit BJ, Tamminga P et al (1997) Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks’ gestation. N Engl J Med 2(336):21–26CrossRef Van Wassenaer AG, Kok JH, De Vijlder JJ, Briet JM, Smit BJ, Tamminga P et al (1997) Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks’ gestation. N Engl J Med 2(336):21–26CrossRef
55.
Zurück zum Zitat Chowdhry P, Scanlon JW, Auerbach R, Abbassi V (1984) Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Paediatrics 73(3):301–305 (PMID: 6366725)CrossRef Chowdhry P, Scanlon JW, Auerbach R, Abbassi V (1984) Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Paediatrics 73(3):301–305 (PMID: 6366725)CrossRef
Metadaten
Titel
Effects of oral iodine supplementation in very low birth weight preterm infants for the prevention of thyroid function alterations during the neonatal period: results of a randomised assessor-blinded pilot trial and neurodevelopmental outcomes at 24 months
verfasst von
S. Ares
B. Saenz-Rico
J. Arnaez
J. Diez-Sebastian
F. Omeñaca
J. Bernal
Publikationsdatum
15.10.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 3/2022
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-021-04288-5

Weitere Artikel der Ausgabe 3/2022

European Journal of Pediatrics 3/2022 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.